Our system has converted vincristine to IVPB to prevent mishaps with inadvertent intrathecal administration. However, we are now faced with other low volume pediatric IV chemo regimens. Our peds group would like these delivered in IV syringes rather than IVPB to decrease volumes lost in IVPB tubing. These regimens are different than vincristine type regimens (IE no IT meds accompanying), but I don’t want to overlook something. How are others handling low volume chemo agents? Do I need to worry about inadvertent intrathecal administrations with other non-vincristine-based regimens?
PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).
Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to firstname.lastname@example.org.